IM Cannabis (IMCC) Other Accumulated Expenses (2023 - 2026)

IM Cannabis' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 37.33% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 37.33% YoY), while the FY2025 annual figure was $4.4 million, up 19.22% from the prior year.
• Other Accumulated Expenses was $3.8 million for Q1 2026 at IM Cannabis, down from $4.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $10.1 million in Q3 2025 to a low of $3.6 million in Q4 2024.
• Historically, Other Accumulated Expenses has averaged $5.5 million across 4 years, with a median of $4.6 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses climbed 21.65% in 2025, then tumbled 37.33% in 2026.
• A 4-year view of Other Accumulated Expenses shows it stood at $4.6 million in 2023, then dropped by 21.62% to $3.6 million in 2024, then advanced by 21.65% to $4.4 million in 2025, then retreated by 12.98% to $3.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $3.8 million (Q1 2026), $4.4 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.